Harold Blalock, MD
Urology · Jackson, MSNPI 1730118696
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.5%), speaking fees and education — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Astellas Pharma US Inc at 54.5% of the total. Reporting peaked in 2019 at $5,854 and has fallen 77.0% since, to $1,348 in 2025. Among urology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 402 payments — averaging $37.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$8K
- Johnson & Johnson$2K
- AbbVie$763
- Sumitomo Pharma America, Inc.$577
- Pfizer$546
- Myriad Genetic Laboratories, Inc.$479
- plus $3K from 37 others
What the payments were for
- Speaking & faculty fees$7,05046%
- Food & beverage$7,38348%
- Education$7465%
- Gifts$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,237 in reported general payments places this provider in the 95th percentile of 94 urology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 163 | $2,155,594 |
| ErleadaApalutamide | 104 | $1,433,204 |
| NubeqaDarolutamide | 27 | $345,434 |
| Abiraterone Acetate | 27 | $121,666 |
| GemtesaVibegron | 178 | $108,159 |
| TrelstarTriptorelin Pamoate | 21 | $97,943 |
| MyrbetriqMirabegron | 123 | $85,868 |
| OrgovyxRelugolix | 15 | $39,981 |
| Tamsulosin Hcl | 765 | $8,291 |
| Dutasteride | 141 | $3,366 |
| Fosfomycin Tromethamine | 12 | $1,743 |
| Oxybutynin Chloride ErOxybutynin Chloride | 112 | $1,560 |
| Testosterone Cypionate | 28 | $1,313 |
| Finasteride | 120 | $1,287 |
| Solifenacin Succinate | 30 | $1,231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $8,300 | $2,241,462286 claims |
| Johnson & JohnsonErleada | $1,936 | $1,433,204104 claims |
| BayerNubeqa | $224 | $345,43427 claims |
| Sumitomo Pharma America, Inc.Gemtesa, Orgovyx | $577 | $148,140193 claims |
| Verity Pharmaceuticals Inc.Trelstar | $122 | $97,94321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 94 urology providers in Mississippi.
Other urology in Jackson
- Patrick DailyJackson$12K
- Mark RunnelsJackson$10K
- Allen HarawayJackson$8K
- John AdamsJackson$8K
- Michael WoodJackson$8K
- Chadwick HuckabayJackson$8K
- Ronald DavisJackson$6K
- Felix Gordon JrJackson$6K
- Kieran HynesJackson$6K
- Matthew MossJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.